Elmehdi Aniq
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elmehdi Aniq has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Mohamed Chakraoui
7 shared publicationsNaoual Mouhni
3 shared publicationsMohammed Jetti
2 shared publicationsAbderrahim Aboulfalah
Cadi Ayyad University
1 shared publicationAyoub Faouzi El-Ghanaoui
1 shared publicationFaouzi-Ayoub EL Ghanaoui
LS2ME, Polydisciplinary Faculty of Khouribga, Sultan Moulay Slimane University, Beni Mellal, Morocco
1 shared publication
Latest Publications
- 18 April 2026
- Published by Springer Nature
- p. 481-493
A Deep Learning Framework Based on Ultrasound Imaging for Breast Cancer Classification
- 18 April 2026
- Published by Springer Nature
- p. 481-493
A Deep Learning Framework Based on Ultrasound Imaging for Breast Cancer Classification
- Open Access
- 11 March 2026
- Published by Elsevier in Informatics in Medicine Unlocked
- Vol. 62
Breast cancer classification in ultrasound imaging using Mamba: An efficient state-space model for computer-aided diagnosis
- 11 March 2026
- Published by Elsevier in Informatics in Medicine Unlocked
- Vol. 62
Open AccessBreast cancer classification in ultrasound imaging using Mamba: An efficient state-space model for computer-aided diagnosis
- Open Access
- 23 June 2025
- Published by International Academic Press in Statistics, Optimization & Information Computing
- Vol. 15 (2) , 1087-1098
Vision Transformers for Breast Cancer Mammographic Image Classification
Background and Objective : The mortality rates due to breast cancer have been constantly growing and still represent one of the most common malignancies leading to death in females globally. Early and accurate detection is crucial to improve the survival rate. Recent deep learning advancements in artificial intelligence have opened a wide new avenue for further improving the results of computer-aided diagnosis. Vision transformers with their attention mechanism are among the recent promising ones, offering much-improved results for different image analysis applications, including mammography. Methods : This study investigates the application of vision transformers and attention mechanisms for mammography image categorization. In this work, we used three publicly available datasets like the Mammographic Image Analysis Society (MIAS), Curated Breast Imaging Subset of DDSM (CBIS-DDSM), and INbreast. In the preprocessing of data, augmentation is used to enhance the generalization capabilities of models, and we have applied Contrast Limited Adaptive Histogram Equalization (CLAHE) to improve the contrast of images, especially in situations characterized by uneven lighting or low contrast levels. Results : The proposed approach demonstrated superior performance compared to traditional convolutional neural network (CNN)-based methods. In the evaluation of this vision transformer, we have obtained an accuracy of 0.99, an AUC of 0.99 and an F1 score of 0.98. Conclusion : Vision transformers and attention mechanisms have great potential to boost the detection of breast cancer using CAD systems. The findings accentuate their capability to improve the precision and reliability of mammography analysis, enabling early diagnosis and minimizing false positives and false negatives in clinical practice. The research emphasizes the need to embrace these new technologies to enhance patient outcomes and streamline healthcare resources.
- 23 June 2025
- Published by International Academic Press in Statistics, Optimization & Information Computing
- Vol. 15 (2) , 1087-1098
Open AccessVision Transformers for Breast Cancer Mammographic Image Classification
Background and Objective : The mortality rates due to breast cancer have been constantly growing and still represent one of the most common malignancies leading to death in females globally. Early and accurate detection is crucial to improve the survival rate. Recent deep learning advancements in artificial intelligence have opened a wide new avenue for further improving the results of computer-aided diagnosis. Vision transformers with their attention mechanism are among the recent promising ones, offering much-improved results for different image analysis applications, including mammography. Methods : This study investigates the application of vision transformers and attention mechanisms for mammography image categorization. In this work, we used three publicly available datasets like the Mammographic Image Analysis Society (MIAS), Curated Breast Imaging Subset of DDSM (CBIS-DDSM), and INbreast. In the preprocessing of data, augmentation is used to enhance the generalization capabilities of models, and we have applied Contrast Limited Adaptive Histogram Equalization (CLAHE) to improve the contrast of images, especially in situations characterized by uneven lighting or low contrast levels. Results : The proposed approach demonstrated superior performance compared to traditional convolutional neural network (CNN)-based methods. In the evaluation of this vision transformer, we have obtained an accuracy of 0.99, an AUC of 0.99 and an F1 score of 0.98. Conclusion : Vision transformers and attention mechanisms have great potential to boost the detection of breast cancer using CAD systems. The findings accentuate their capability to improve the precision and reliability of mammography analysis, enabling early diagnosis and minimizing false positives and false negatives in clinical practice. The research emphasizes the need to embrace these new technologies to enhance patient outcomes and streamline healthcare resources.
- 6 November 2024
- Published by Emerald Publishing in Data Technologies and Applications
- Vol. 59 (2) , 216-230
AI-powered precision: breast carcinoma diagnosis through digital proliferation index (Ki-67) assessment in pathological anatomy
Purpose: The primary objective of the study is to enhance the accuracy and efficiency of assessing the proliferation index in cancer cells, specifically focusing on the role of Ki-67. The purpose is to address the limitations of traditional visual assessments conducted by pathologists by integrating AI technologies, particularly deep learning. By accurately computing the percentage of Ki-67-labeled cells, the research aims to streamline the diagnostic process, reduce subjectivity and contribute to the advancement of diagnostic precision in pathological anatomy.Design/methodology/approach: The research employs a methodological approach that integrates Ki-67, a non-histone nuclear protein, as a vital biomarker for assessing the proliferative status of cancer cells. Given the challenges associated with traditional visual assessments by pathologists, including inter- and intra-observer variability and time-consuming efforts, the study adopts a novel methodology leveraging artificial intelligence (AI) solutions. Deep learning is applied to precisely calculate the percentage of Ki-67-labeled cells. The process involves pathologists delineating the tumor area at x40 magnification, enabling the segmentation of various cell types (positive, negative and tumor-infiltrating lymphocytes). The subsequent percentage calculation enhances efficiency and minimizes subjectivity in the diagnostic process.Findings: Despite inherent errors, the research findings indicate that the model surpasses existing benchmarks, showcasing superior accuracy in terms of average error measurement. The comparison with diverse datasets and benchmarking against pathologists’ diagnoses contributes empirical evidence to support the effectiveness of the AI-based model in accurately computing the percentage of Ki-67-labeled cells. These findings signify a noteworthy advancement in diagnostic methodologies and reinforce the potential of AI technologies in improving the precision of cancer diagnostics within the realm of pathological anatomy.Originality/value: The research contributes to the field by introducing an innovative approach that combines Ki-67 as a biomarker and AI technologies for improved diagnostic precision. The originality lies in the utilization of deep learning to calculate the percentage of labeled cells, mitigating the challenges associated with manual assessments. The validation of the model against diverse datasets and benchmarking against pathologists’ diagnoses demonstrates its superior accuracy, highlighting the value of integrating AI in pathological anatomy for enhanced diagnostic outcomes. The study represents a significant stride in original research, offering novel insights and methodologies in the pursuit of more precise cancer diagnostics.
- 6 November 2024
- Published by Emerald Publishing in Data Technologies and Applications
- Vol. 59 (2) , 216-230
AI-powered precision: breast carcinoma diagnosis through digital proliferation index (Ki-67) assessment in pathological anatomy
Purpose: The primary objective of the study is to enhance the accuracy and efficiency of assessing the proliferation index in cancer cells, specifically focusing on the role of Ki-67. The purpose is to address the limitations of traditional visual assessments conducted by pathologists by integrating AI technologies, particularly deep learning. By accurately computing the percentage of Ki-67-labeled cells, the research aims to streamline the diagnostic process, reduce subjectivity and contribute to the advancement of diagnostic precision in pathological anatomy.Design/methodology/approach: The research employs a methodological approach that integrates Ki-67, a non-histone nuclear protein, as a vital biomarker for assessing the proliferative status of cancer cells. Given the challenges associated with traditional visual assessments by pathologists, including inter- and intra-observer variability and time-consuming efforts, the study adopts a novel methodology leveraging artificial intelligence (AI) solutions. Deep learning is applied to precisely calculate the percentage of Ki-67-labeled cells. The process involves pathologists delineating the tumor area at x40 magnification, enabling the segmentation of various cell types (positive, negative and tumor-infiltrating lymphocytes). The subsequent percentage calculation enhances efficiency and minimizes subjectivity in the diagnostic process.Findings: Despite inherent errors, the research findings indicate that the model surpasses existing benchmarks, showcasing superior accuracy in terms of average error measurement. The comparison with diverse datasets and benchmarking against pathologists’ diagnoses contributes empirical evidence to support the effectiveness of the AI-based model in accurately computing the percentage of Ki-67-labeled cells. These findings signify a noteworthy advancement in diagnostic methodologies and reinforce the potential of AI technologies in improving the precision of cancer diagnostics within the realm of pathological anatomy.Originality/value: The research contributes to the field by introducing an innovative approach that combines Ki-67 as a biomarker and AI technologies for improved diagnostic precision. The originality lies in the utilization of deep learning to calculate the percentage of labeled cells, mitigating the challenges associated with manual assessments. The validation of the model against diverse datasets and benchmarking against pathologists’ diagnoses demonstrates its superior accuracy, highlighting the value of integrating AI in pathological anatomy for enhanced diagnostic outcomes. The study represents a significant stride in original research, offering novel insights and methodologies in the pursuit of more precise cancer diagnostics.
- Open Access
- 21 August 2024
- Published by International Information and Engineering Technology Association in Ingénierie des Systèmes d'information
- Vol. 29 (4) , 1603-1609
Innovative: A Novel Deep Learning-Based Semantic Segmentation Architecture for Medical Applications
- 21 August 2024
- Published by International Information and Engineering Technology Association in Ingénierie des Systèmes d'information
- Vol. 29 (4) , 1603-1609
Open AccessInnovative: A Novel Deep Learning-Based Semantic Segmentation Architecture for Medical Applications
- 16 February 2024
- Published by Springer Nature
- p. 550-558
Breast Cancer Stage Determination Using Deep Learning
- 16 February 2024
- Published by Springer Nature
- p. 550-558
Breast Cancer Stage Determination Using Deep Learning
- 6 January 2024
- Published by Springer Nature in Artificial Life and Robotics
- Vol. 29 (1) , 177-186
Artificial intelligence in pathological anatomy: digitization of the calculation of the proliferation index (Ki-67) in breast carcinoma
- 6 January 2024
- Published by Springer Nature in Artificial Life and Robotics
- Vol. 29 (1) , 177-186
Artificial intelligence in pathological anatomy: digitization of the calculation of the proliferation index (Ki-67) in breast carcinoma